Maravai LifeSciences Holdings, Inc. (MRVI) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Maravai LifeSciences Holdings, Inc. (MRVI) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$38.42 MLiabilities$248.16 MCurrent assets$155.66 MNon-current liabilities$209.74 MAssets$603.75 MNon-current assets$448.09 MEquity$355.59 MGross equity(calculated)$361.62 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsInventoryAccounts receivable, netPrepaid expenses and other current assetsProperty and equipment, netIntangible assets, netGoodwillOther assetsAccrued expenses and other current liabilitiesAccounts payableCurrent portion of long-term debtLong-term debt, less current portionOther long-term liabilitiesFinance lease liabilities, less current portionAdditional paid-in capitalCommon stock - Class A Common StockCommon stock - Class B Common StockAccumulated other comprehensive incomeNon-controlling interestCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Retained earnings (accumulated deficit)Accrued expenses and other current liabilitiesAccrued expenses and other current liabilities$30.17 MCurrent liabilitiesCurrent liabilities$38.42 MAccounts payableAccounts payable$7.13 MLiabilitiesLiabilities$248.16 MCurrent portion of long-term debtCurrent portion of long-term debt$1.13 MCurrent assetsCurrent assets$155.66 MCash and cash equivalentsCash and cash equivalents$70.09 MNon-current liabilitiesNon-current liabilities$209.74 MAssetsAssets$603.75 MInventoryInventory$41.23 MLong-term debt, less current portionLong-term debt, less current portion$145.98 MAccounts receivable, netAccounts receivable, net$31.14 MOther long-term liabilitiesOther long-term liabilities$34.17 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$13.20 MNon-current assetsNon-current assets$448.09 MFinance lease liabilities, less current portionFinance lease liabilities, less current portion$29.59 MEquityEquity$355.59 MProperty and equipment, netProperty and equipment, net$142.41 MGross equity (calculated)Gross equity(calculated)$361.62 MAdditional paid-in capitalAdditional paid-in capital$207.60 MIntangible assets, netIntangible assets, net$138.38 MCommon stock - Class A Common StockCommon stock - Class A Common Stock$1.49 MGoodwillGoodwill$129.43 MCommon stock - Class B Common StockCommon stock - Class B Common Stock$1.11 MOther assetsOther assets$37.87 MAccumulated other comprehensive incomeAccumulated other comprehensive income$459.00 KNon-controlling interestNon-controlling interest$150.97 MRetained earnings (accumulated deficit)Retained earnings (accumulated deficit)−$6.03 M
Chart details

Maravai LifeSciences Holdings, Inc. (MRVI) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
603,746,000 US dollars
Current assets
155,655,000 US dollars
Non-current assets
448,091,000 US dollars
Liabilities
248,158,000 US dollars
Current liabilities
38,419,000 US dollars
Non-current liabilities
209,739,000 US dollars
Equity
355,588,000 US dollars
Noncontrolling interest
150,966,000 US dollars. Included in consolidated equity; this amount is not added again.
Cash and cash equivalents
70,091,000 US dollars
Inventory
41,230,000 US dollars
Accounts receivable, net
31,138,000 US dollars
Prepaid expenses and other current assets
13,196,000 US dollars
Property and equipment, net
142,414,000 US dollars
Intangible assets, net
138,375,000 US dollars
Goodwill
129,429,000 US dollars
Other assets
37,873,000 US dollars
Accrued expenses and other current liabilities
30,169,000 US dollars
Accounts payable
7,125,000 US dollars
Current portion of long-term debt
1,125,000 US dollars
Long-term debt, less current portion
145,980,000 US dollars
Other long-term liabilities
34,168,000 US dollars
Finance lease liabilities, less current portion
29,591,000 US dollars
Additional paid-in capital
207,598,000 US dollars
Common stock - Class A Common Stock
1,489,000 US dollars
Common stock - Class B Common Stock
1,107,000 US dollars
Accumulated other comprehensive income
459,000 US dollars
Non-controlling interest
150,966,000 US dollars
Retained earnings (accumulated deficit)
negative 6,031,000 US dollars
Gross equity (calculated)
361,619,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Maravai LifeSciences Holdings, Inc. (MRVI) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!